当前位置: 首页 > 期刊 > 《中国现代医生》 > 2011年第36期 > 正文
编号:12144115
美沙拉嗪缓释颗粒对溃疡性结肠炎患者血清IL-6、TNF-α影响机制的研究(1)
http://www.100md.com 2011年12月25日 陈强妹
第1页

    参见附件(1910KB,2页)。

     [摘要] 目的 探讨美沙拉嗪缓释颗粒对溃疡性结肠炎患者的疗效,以及对血清白介素(IL-6)、肿瘤坏死因子(TNF-α)影响机制的研究。方法 入院确诊的70例溃疡性结肠炎患者随机分为治疗组(美沙拉嗪缓释颗粒)和对照组(SASP)各35例,比较两组治疗前后肠镜变化、临床疗效及血清IL-6、TNF-α的变化情况。结果 治疗组的疗效优于对照组(P<0.01)。两组治疗后的IL-6、TNF-α较治疗前明显降低,P<0.01,t值分别为12.36,12.75,12.24,12.42,且治疗组的降低程度较对照组更明显,差异有统计学意义,t值分别为12.27,12.35,P<0.01。 结论 美沙拉嗪缓释颗粒治疗溃疡性结肠炎可显著提高临床疗效,考虑可能是通过降低IL-6水平、TNF-α而起作用的,其具体机制尚有待进一步研究。

    [关键词] 溃疡性结肠炎;美沙拉嗪缓释颗粒;血清白介素(IL-6);肿瘤坏死因子(TNF-α)

    [中图分类号] R574.1 [文献标识码] B [文章编号] 1673-9701(2011)36-34-02

    The Study of the Mechanism of Mesalazine Release Granules on Serum IL-6,TNF-α in Ulcerative Colitis Patients

    CHEN Qiangmei

    Zhejiang Province Tonglu Country MCH,Tonglu 311500,China

    [Abstract] Objective To investigate the efficacy of mesalazine on the of ulcerative colitis,and to explore the mechanism of serum interleukin(IL-6), tumor necrosis factor(TNF-α) in UC. Methods All of 70 patients with ulcerative colitis were randomly divided into treatment groups(mesalazine slow-release granules) and the control group(SASP) two groups,each 35 cases,endoscopic changes and clinical efficacy and serum IL-6,TNF-α changes were compared before and after treatment. Results The efficacy of the treatment group was better than the control group(P<0.01). After treatment, the levels of IL-6 was significantly lower than before treatment,the treatment group decreased level of serum IL-6 was more significantly than the control group, the difference was statistically significant,P<0.01. Conclusion Mesalazine slowes release granules for ulcerative colitis,and it can significantly improve the clinical efficacy,consideration may be by reducing the level of IL-6 play a role,the specific mechanism remains to be further studied.

    [Key words] Ulcerative colitis;Mesalazine slow release granules;Serum interleukin(IL-6);Tumor necrosis factor(TNF-α)

    溃疡性结肠炎是消化系的常见病、多发病,近年来,其发病率逐年升高,目前临床治疗溃疡性结肠炎的方法较多,且疗效报道不一[1]。研究发现,白介素(IL)在溃疡性结肠炎(UC)的发病中起了重要作用,其中IL-6分泌增加影响肠上皮细胞电解质分泌紊乱,介导了其他炎性细胞发生炎性反应[2]。本研究旨在探讨美沙拉嗪缓释颗粒对溃疡性结肠炎患者的疗效,以及对血清白介素(IL-6)、TNF-α的影响机制,现报道如下。

    1 资料与方法

    1.1一般资料

    我院2009年2月~2010年2月入院确诊的70例溃疡性结肠炎患者,符合 2000年全国炎症性肠病学术会议修改的溃疡性结肠炎诊断标准[3],排除有患有严重心、肝、肾等重要脏器疾病或血液、内分泌系统疾病患者、消化道肿瘤、对水杨酸类药物过敏者及精神障碍疾病者 ......

您现在查看是摘要介绍页,详见PDF附件(1910KB,2页)